Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Kubrak

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Medicinal Chemistry|August 1, 1986
Synthesis of [[(naphthalenylmethoxy)- and [[(quinolinylmethoxy)phenyl]amino]oxoalkanoic acid esters. A novel series of leukotriene D4 antagonists and 5-lipoxygenase inhibitorsJ H Musser, D M Kubrak, J Chang, et al.
Journal of Medicinal Chemistry|February 1, 1987
Leukotriene D4 antagonists and 5-lipoxygenase inhibitors. Synthesis of benzoheterocyclic [(methoxyphenyl)amino]oxoalkanoic acid estersJ H Musser, D M Kubrak, J Chang, et al.
Journal of Medicinal Chemistry|June 1, 1989
N-[(arylmethoxy)phenyl] and N-[(arylmethoxy)naphthyl] sulfonamides: potent orally active leukotriene D4 antagonists of novel structureJ H Musser, A F Kreft, R H Bender, et al.
Journal of Medicinal Chemistry|January 1, 1990
N-[(arylmethoxy)phenyl] carboxylic acids, hydroxamic acids, tetrazoles, and sulfonyl carboxamides. Potent orally active leukotriene D4 antagonists of novel structureJ H Musser, A F Kreft, R H Bender, et al.
Journal of Medicinal Chemistry|November 1, 1987
Phenylephrine derivatives as leukotriene D4 antagonistsJ H Musser, D M Kubrak, R H Bender, et al.
Drugs Under Experimental and Clinical Research|January 1, 1991
Conversion of a cyclooxygenase (CO) inhibitor into a 5-lipoxygenase (LO) inhibitor: a general route to novel orally active anti-inflammatory and anti-allergy drugsA F Kreft, A A Failli, J H Musser, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Medicinal Chemistry|August 1, 1986
Synthesis of [[(naphthalenylmethoxy)- and [[(quinolinylmethoxy)phenyl]amino]oxoalkanoic acid esters. A novel series of leukotriene D4 antagonists and 5-lipoxygenase inhibitorsJ H Musser, D M Kubrak, J Chang, et al.
Journal of Medicinal Chemistry|February 1, 1987
Leukotriene D4 antagonists and 5-lipoxygenase inhibitors. Synthesis of benzoheterocyclic [(methoxyphenyl)amino]oxoalkanoic acid estersJ H Musser, D M Kubrak, J Chang, et al.
Journal of Medicinal Chemistry|June 1, 1989
N-[(arylmethoxy)phenyl] and N-[(arylmethoxy)naphthyl] sulfonamides: potent orally active leukotriene D4 antagonists of novel structureJ H Musser, A F Kreft, R H Bender, et al.
Journal of Medicinal Chemistry|January 1, 1990
N-[(arylmethoxy)phenyl] carboxylic acids, hydroxamic acids, tetrazoles, and sulfonyl carboxamides. Potent orally active leukotriene D4 antagonists of novel structureJ H Musser, A F Kreft, R H Bender, et al.
Journal of Medicinal Chemistry|November 1, 1987
Phenylephrine derivatives as leukotriene D4 antagonistsJ H Musser, D M Kubrak, R H Bender, et al.
Drugs Under Experimental and Clinical Research|January 1, 1991
Conversion of a cyclooxygenase (CO) inhibitor into a 5-lipoxygenase (LO) inhibitor: a general route to novel orally active anti-inflammatory and anti-allergy drugsA F Kreft, A A Failli, J H Musser, et al.
Pageof 1